Vectus Biosystems Limited (ASX:VBS)
Australia flag Australia · Delayed Price · Currency is AUD
0.0830
0.00 (0.00%)
Aug 29, 2025, 3:28 PM AEST

Vectus Biosystems Revenue

Vectus Biosystems had revenue of 393.71K AUD in the half year ending December 31, 2024, a decrease of -32.03%. This brings the company's revenue in the last twelve months to 884.21K, down -37.88% year-over-year. In the fiscal year ending June 30, 2024, Vectus Biosystems had annual revenue of 1.14M, down -15.94%.

Revenue (ttm)
884.21K
Revenue Growth
-37.88%
P/S Ratio
5.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20241.14M-215.86K-15.94%
Jun 30, 20231.35M54.45K4.19%
Jun 30, 20221.30M282.09K27.71%
Jun 30, 20211.02M966.81K1,888.82%
Jun 30, 202051.19K50.97K23,166.36%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.12B
Telix Pharmaceuticals1.01B
Ansell3.06B
Mesoblast9.16M
Revenue Rankings